Posted on 8/6/19
Seres Therapeutics Reports Second Quarter Financial Results and Provides Progress Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc. (Nasdaq: MCRB) today reported second quarter 2019 financial results and provided business updates.“We remain focused on the execution of our clinical . . .
Posted on 8/6/19
Kala Pharmaceuticals Reports Second Quarter 2019 Financial Results
WATERTOWN, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (Kala) (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY mucus-penetrating particle (MPP) Drug . . .
Posted on 8/6/19
Neon Therapeutics Reports Second Quarter 2019 Financial Results
CAMBRIDGE, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today reported financial results for the . . .
Posted on 8/6/19
Karyopharm Reports Second Quarter 2019 Financial Results and Highlights Recent Company Progress
NEWTON, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an oncology-focused pharmaceutical company, today reported financial results for the second quarter 2019. In . . .
Posted on 8/5/19
CVS Pharmacy Expands CarePass Program Nationwide
CVS Pharmacy, the retail division of CVS Health (NYSE: CVS), announced that this week, customers will be able to enroll in CarePass at participating CVS Pharmacy . . .
Posted on 8/5/19
Arvinas Reports Second Quarter 2019 Financial Results and Provides Corporate Update
NEW HAVEN, Conn., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of drugs based on targeted protein . . .
Posted on 8/5/19
2019’s Best & Worst States for Health Care – WalletHub Study
According to the CDC, 87.6 percent of the population has a regular place to go for medical care. But the cost and service quality of that . . .
Posted on 8/5/19
Bristol-Myers Looks Incredibly Cheap
SummaryBMY just posted solid Q2 results which included double-digit top- and bottom-line growth.The company trades for just 10x earnings and offers a safe, 3.6% dividend yield.The . . .
Posted on 8/5/19
3 Things You Can Expect With CVS Health's Q2 Earnings Update
CVS Health (NYSE:CVS) surprised some investors in the first quarter with its solid revenue and earnings growth. At the time, CEO Larry Merlo expressed optimism that . . .
Posted on 8/5/19
IDEXX Labs Fetches Double-Digit Profit Growth
IDEXX Laboratories (NASDAQ:IDXX), a diversified pet healthcare company, reported its second-quarter results on Thursday.Revenue growth held steady at 7%, although the number would have been a . . .
Posted on 8/5/19
Exicure Closes its Offering of Common Stock
CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) constructs, today announced the closing . . .
Posted on 8/1/19
Ironwood Pharmaceuticals' Blowout Q2 Results: What You'll Want to Know
Ironwood Pharmaceuticals (NASDAQ:IRWD) shareholders couldn't have been happy campers when the drugmaker reported its quarterly results in May. The company announced that revenue dropped by 0.6% . . .
Posted on 7/31/19
Translate Bio Announces Second Quarter 2019 Financial Results and Provides Corporate Update
LEXINGTON, Mass., July 31, 2019 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative . . .
Posted on 7/31/19
Shields Health Solutions Receives Equity Investments From Welsh, Carson, Anderson & Stowe and Walgreen
STOUGHTON, Mass. & NEW YORK & DEERFIELD, Ill.--(BUSINESS WIRE)--Shields Health Solutions, Welsh, Carson, Anderson & Stowe and Walgreen Co. today announced the parties have entered into a . . .
Posted on 7/31/19
Flexion Therapeutics: The Time To Buy Is Now
SummaryFlexion has gone through its fair share of woes, but things seem to be at an inflection point.A significant ramp in sales has just begun.Most downside . . .
Posted on 7/31/19
Biogen Hedged Its Bet and Won Big
Sometimes a drugmaker's best move isn't developing a new drug but protecting sales of an established one.Sales of Biogen's (NASDAQ:BIIB) top-selling multiple sclerosis drug Tecfidera brought . . .
Posted on 7/31/19
Exicure Proposes Public Offering of Common Stock
CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc. (OTCQB: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) constructs, announced today that it . . .
Posted on 7/30/19
Infinity Pharmaceuticals Provides Company Update
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced its second quarter 2019 financial results and provided an update on the company, including its progress with IPI-549, a . . .
Posted on 7/30/19
PROMETRIKA Partners with Comprehend
PROMETRIKA, LLC and Comprehend Systems, Inc. are proud to announce a partnership that will provide innovative solutions to meet the evolving needs of biotech and pharmaceutical . . .
Posted on 7/30/19
Cognex Corporation (CGNX) CEO Robert Willett on Q2 2019 Results - Earnings Call Transcript
Cognex Corporation (NASDAQ:CGNX) Q2 2019 Earnings Conference Call July 29, 2019 5:00 PM ETCompany ParticipantsSusan Conway - Head of Investor RelationsRobert Shillman - ChairmanRobert Willett - . . .
Posted on 7/30/19
Berkshire Hathaway: If You Can't Value It, Don't Buy It
SummaryBerkshire Hathaway is an extremely complex corporation to value.Berkshire Hathaway is expensive at current market price.The price that you pay is very important in any investment . . .
Posted on 7/30/19
Better Buy: Rite Aid vs. CVS Health
Rite Aid (NYSE:RAD) and CVS Health (NYSE:CVS) are two of the largest retail drugstore chains in the U.S. Both face near-term and long-term challenges that have . . .
Posted on 8/8/19
Cambridge BioMarketing Recognized with Recent Awards
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cambridge BioMarketing, an Ashfield company, part of UDG Healthcare plc and the world’s leading rare disease agency, today announced it has been recognized with . . .
Posted on 7/29/19
Cara Therapeutics Closes Public Offering of Common Stock
STAMFORD, Conn., July 29, 2019 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed . . .
Posted on 7/29/19
Innovation Pharmaceuticals Provides Corporate Update
BEVERLY, Mass., July 29, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX), a clinical stage biopharmaceutical company, is pleased to provide a corporate update highlighting recent accomplishments, . . .

